The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
Objective: Recent studies have reported conflicting results on the correlation between metformin use and outcomes in patients with colorectal cancer (CRC). A meta-analysis was performed to evaluate the efficacy of metformin therapy on the prognosis of CRC patients with type 2 diabetes mellitus (T2DM...
Guardado en:
Autores principales: | Shan Tian, Hong-Bo Lei, Yu-Lan Liu, Yan Chen, Wei-Guo Dong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9c77016dbd541e48ce403e67cc79aae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
por: Xiaogang Li, et al.
Publicado: (2017) -
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holl, et al.
Publicado: (2014) -
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang Q, et al.
Publicado: (2020) -
The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
por: Manal Mohammed Hashem, et al.
Publicado: (2021) -
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
por: Lev Mikhaylovich Bershteyn, et al.
Publicado: (2014)